Pacific Biosciences of California, Inc. (PACB)
NASDAQ · Healthcare
Pacific Biosciences of California, Inc. EPS 2009–2025
Pacific Biosciences of California, Inc. annual/quarterly eps history and growth rate from 2018 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Pacific Biosciences of California, Inc. eps for the quarter ending March 31, 2026 was $0.03, a 97.92% decrease year-over-year.
- Pacific Biosciences of California, Inc. annual eps for 2025 was $1.82, a 14.47% increase from 2024.
- Pacific Biosciences of California, Inc. annual eps for 2024 was $1.59, a 31.40% increase from 2023.
- Pacific Biosciences of California, Inc. annual eps for 2023 was $1.21, a 13.57% decrease from 2022.
- Pacific Biosciences of California, Inc. annual eps for 2022 was $1.40.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Pacific Biosciences of California, Inc. EPS — FAQ
Pacific Biosciences of California, Inc. (PACB) eps over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Pacific Biosciences of California, Inc.'s eps?
Pacific Biosciences of California, Inc. (PACB) reported eps of $-1.82 for fiscal 2025.
Where can I see PACB's eps history?
The chart and table above show Pacific Biosciences of California, Inc.'s eps by year and by quarter, including the growth rate.